人福医药：因披露的年度报告财务指标存在虚假记载 股票将被实施其他风险警示 证券简称变更为ST人福

Core Points - The company received an administrative penalty notice from the Hubei Regulatory Bureau of the China Securities Regulatory Commission on December 12, 2025, indicating that the financial indicators disclosed in its annual report contained false records [1] - The financial indicators in question include operating income, total profit, net profit, and items in the balance sheet such as assets or liabilities [1] - As a result of these findings, the company's stock will be subject to other risk warnings, and it will be designated as ST Renfu starting December 15, with a one-day trading suspension [1]